Clinical trial
Autologous Cardiac Stem Cell Injection in Patients With Hypoplastic Left Heart Syndrome: An Open Label Pilot Study.
NCT03406884 is registered in ClinicalTrials.gov with Joshua M Hare as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Autologous Cardiac Stem Cell Injection in Patients With Hypoplastic Left Heart Syndrome: An Open Label Pilot Study.
- Lead sponsor
- Joshua M Hare
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 16, 2019
- Completion date
- July 1, 2024
- Enrollment
- 25 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.